skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Peter have just sold my Catamaran...am looking to stay in the same sector I already own GUD + PHM + MRE...do you have any suggestions. Staying with a health care provider would be first choice (I think) I am about 4% invested in the sector.
Read Answer Asked by Terence on April 14, 2015
Q: Merus made a move yesterday involving 60 million dollars. Do you see this as a good move and is it worth adding stock to my position?

Thanks, Charlie
Read Answer Asked by Charlie on April 14, 2015
Q: I have a question regarding the recently upsized bought deal of $58.5M. In the past, I have felt as though many "upsized" deals come about due to external demand and promotion by the underwriting syndicate to company management. This can be a negative as the incremental capital raised likely has no immediate place to go(otherwise, why not start at the higher sized offering to begin with...), and this can result in shareholder dilution.

I realize PHM is a role up company and currently on an acquisition spree so this may not apply to them but what do you make of this increased deal size? I worry about all the extra dilution.

Thanks.
Read Answer Asked by Scott on April 13, 2015
Q: Hi folks,can please get update on Merus labs and finace @ $3.05,where would u rank the stock in relation to other Cdn biotech comps;buy,hold or sell.Thanks as always jb
Read Answer Asked by John on April 13, 2015
Q: Would you recommend GUD over CXR for a 5-7 year hold? I feel like I might be chasing CXR at this point and that GUD has more upside (with the risk of being a smaller cap).

Thanks, Neil
Read Answer Asked by Neil on April 13, 2015
Q: I recently bought Cipher on its pullback. ? thoughts on today's announced acquisition of US private pharmaceutical Innocutis. Market seems to like it a lot.
Thanks
Read Answer Asked by richard on April 13, 2015
Q: I notice this Co. on the new highs list.
May I have your opinion please.
Read Answer Asked by claudette on April 11, 2015
Q: Three insiders have bought recently, but it has no revenue and is only in phase two trials. Do they have enough money to continue, or is this just a hope that someone will buy them? If it works, they're worth a fortune.
Read Answer Asked by John on April 11, 2015
Q: Each Subscription Receipt will entitle the holder thereof to receive, upon the closing of the Acquisition, without payment of additional consideration or further action, one Concordia common share in exchange for each Subscription Receipt.

Why companies sell subscription receipts instead os shares? Should I buy the shares or the receipts?

Regards

Read Answer Asked by Claude on April 11, 2015
Q: Yesterday, a member asked if we could see any news about RX.V. The company "advises that it is not aware of any material undisclosed business development that should account for the decrease in its stock price". Source: http://www.stockhouse.com/news/press-releases/2015/04/10/biosyent-comments-on-recent-market-activity. The stock is now up 9%.
Read Answer Asked by Matt on April 10, 2015
Q: I own just a few shares of Concordia. . Would a few hundred shares bought in my rrsp at these prices make sense. It just keeps climbing.
Read Answer Asked by Helen on April 10, 2015
Q: Pli closed today at $ 2.72 - how much of the price do you think is related to speculation regarding the upcoming level 2 drug trials and do they have sufficient funds to complete the trials or wifi they require an equity raise? Many thanks
Read Answer Asked by Tom on April 10, 2015
Q: Intially thanks for the excellent recommendation, just wish I was in a little earlier than $71.00
Researching this puppy, located different PE's--1@224.90 and 2nd@90.00. Webroker has 6 buys, and 3 strong buys and today a recommendation to $115.00 plus. Yesterday there was a halt which I could not locate info on.
EPS forecasted of 6.00 2015-16. This is totally attributed to the Covis purchase of 1.2 billion with an 18 drug portfolio,and hersay, they are looking at additional acquisitions which could result in considerable upside for the company. If Covis closes as scheduled, projected to trade at 17.2 x f2015 and 11xf2016. Do these appear reasonable.
This stock without a doubt has been the quickest most profitable stock (15 days) I have ever purchased in my 40 years of trading, and is creeping up to 9% of my RRSP portfolio.
In the event of a market correction or a downturn of 10-20% what are your thoughts.
What's your thoughts on management, and have you met them personally
I am certainly prepared to hold for the long haul, but would not certainly like to this blow up eg fraud, compliance etc
Many thanks
Rick
Read Answer Asked by Rick on April 10, 2015
Q: Hello, just wondering if you would hold onto prgo at this point or sell, had a 20% pop today. I have a 3% position. Thanks for your opinion
Read Answer Asked by Sheldon on April 09, 2015
Q: CCT has been sliding over the past few sessions. When does this become a buying opportunity. Are there any new risks since the buyout announcement that are motivating the sellers. Thanks.
Read Answer Asked by Brad on April 07, 2015
Q: I own CCT on the tsx - will the price continue to fluctuate based on exchange rate until the deal is closed, and therefore, if C$ continues to slide, it is better to hold for now and look at selling if there seems to be some strength coming back in the C$ ?
Read Answer Asked by Alexandra on March 30, 2015
Q: As do some of the other members I own some Catamaran (wish I had more). I am wondering if you have had time to consider any good candidates worthy of analysis to replace it?
Many thanks
Mike
Read Answer Asked by michael on March 30, 2015
Q: Hello Peter & Co,
I hold CCT and would make 50% in 7 months if I sold now; but what about the challenges by a couple of Law firms?
Thanks,
Antoine
Read Answer Asked by Antoine on March 30, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!